Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«S100A4

Below is an extended S100A4 publications listing. Click here to return to the gene page.

Gene Information from Publications

Publication Link Summary of findings
17497677 Pathways of signaling by S100A4, by its interaction with and sequestration of p53, and by Notch also seem differentially operational in the induction of apoptosis
18154362 Localized activation of S100A4 at the cell periphery was observed in fibroblasts during random migration and following stimulation with lysophosphatidic acid, a known activator of cell motility and proliferation.
17673926 Hypomethylation is an important mechanism of regulating the expression of the S100A4 gene in endometrial carcinomas.
17565747 Results show that S100A4 is expressed preferentially by various cell types present in the tumor microenvironment (macrophages, fibroblasts, activated lymphocytes), rather than by the tumor cells themselves.
17550972 Results suggest that CTGF plays a crucial role in migratory/invasive processes in human breast cancer by a mechanism involving activation of the integrin-alphavbeta3-ERK1/2-S100A4 pathway.
16243835 S100A4 is a mediator of metastasis [review]
14640694 MTS1 regulates nonmuscle myosin IIA assembly by monomer sequestration and is able to regulate cell shape and motility through the modulation of myosin-IIA function.
17504119 Review of implications of S11A4 involvement with and binding to its targets sheds additional light on the role of S100A4 in the control of tumor cell motility and migration.
12645008 S100A4 showed the weakest expression of 3 S100 proteins (including S100A5 and S100A13) in the cells and fibers of the hippocampus and the temporal cortex at all stages examined (from 12 to 33 weeks of gestation).
16265347 overexpression of S100A4 is associated with thyroid tumour invasion and metastasis and it may be a potential target for therapeutic intervention
16571622 S100A4 is expressed in leiomyomas and myometrium with relative expression level inversely correlating with TGF-beta.
15334597 Mts1 acts as a neuroprotectant in primary cerebellar, dopaminergic, and hippocampal neurons induced to undergo cell death.
11875708 The level of S100A4 mRNA is higher in carcinomas compared to normal specimens.
16984379 The nuclear expression of S100A4 is involved in the aggressive behavior of ovarian carcinoma and S100A4 is an autocrine/paracrine factor that plays an important role in the aggressiveness of ovarian carcinoma cells.
11994292 the functional role of S100A4 in regulating endothelial cell growth and tumor metastasis involves interaction with the N-terminal half of Methionine Aminopeptidase 2.
15788416 S100A4 protein alone or in a complex with annexin II accelerated tissue plasminogen activator-mediated plasminogen activation in solution and on the endothelial cell surface
12517790 S100A4 is a direct target of ERBB2 signaling in medulloblastoma cells
12239456 observed differential expression of S100A6 and S100A4 suggests that S100A6, rather than S100A4, is associated with human colorectal adenocarcinoma tumorigenesis and invasion/metastasis
12532418 Expression of mts1 mRNA was affected by E-cadherin transfection. Loss of E-cadherin expression followed by mts1 expression may be important for increasing cell proliferation, motility & invasion activity in the progression of gall bladder cancer.
12756252 S100A4 localizes to the leading edge in a calcium-independent manner
15713996 These findings suggest that (1) S100A4 plays a constitutive role in papillary carcinoma and (2) S100A4 may be a useful marker for early the detection of this carcinoma
14713104 one of the mechanisms by which S100A4 may exert its effect on metastasis of some tumors is by regulating the MMP-2 activity.
12379109 Each subunit of S100A4 has two EF-hand Ca2+-binding domains: a pseudo-EF-hand (or S100-hand) formed by helices 1 and 2 that adopts a conformation similar to other members of the S100 family, and a typical EF-hand.
15781852 S100A4 regulates the oligomerization of p53 tumor suppressor by binding to its tetramerization domain.
15956747 downregulation of mRNA and protein of the calcium binding protein S100A4 (metastasin) in MDA-MB-231/pIRES-EGFP-H2 transfectants
16554030 These data suggest that S100A4, like SPARC, plays a supportive role in early in vitro cardiomyogenesis.
16685438 high S100A4 expression is related to a poor prognosis through hematogenous metastasis in pulmonary adenocarcinoma.
17200116 Increased expression of S100A4 was observed in the medulla and papilla, but not the cortex of a human kidney in response to hypertonic stress
15852272 S100A4 may exert its effect on invasion and metastasis of neuroblastoma cells by stimulating the motility of tumor cells as well as influencing the expression of MMP-2
16990429 These data demonstrate that the S100A4 gene controls the invasive potential of human CaP cells through regulation of MMP-9 and that this association may contribute to metastasis of CaP cells.
17051636 All the data in the present study suggested that S100A4 might contribute to HCC invasion and metastasis through two paths of matrix metalloproteinase (MMP9) secretion regulation and strengthened motility and invasion properties.
17223348 high-grade glioblastomas express higher amount of S100A4/Mts1 than low-grade astrocytic tumors
17276942 Expression of S100A4 protein was observed in 8 invasive carcinomas (80%), 5 high-grade dysphasia/carcinoma in situ cases (83%), and 0 low-grade dysplasia.
12445462 S100A4 stimulates the migration rate of astrocytic tumor cells by modifying the organization of their actin cytoskeleton.
15579771 S100A4 is involved in tumor progression and metastasis. It may be a potential target for therapeutic intervention.
16367903 Involvement of S100A2 and S100A4 in the progression of lung adenocarcinomas provides a list of targets regulated by S100A2 and S100A4.
12168821 Mutations of the cell cycle arrest gene p21WAF1, but not the metastasis-inducing gene S100A4, are frequent in oral squamous cell carcinomas from Sudanese toombak dippers and non-snuff-dippers from the Sudan, Scandinavia, USA and UK.
11752788 crystallization and crystallographic analysis of structure
16097057 Overexpression of S100A4 may be closely related with the aggressiveness of colorectal carcinoma.
16489073 Resaults suggest that in human breast cancer, S100A4 exerts some of its effects through angiogenesis.
16865243 S100A4 overexpression combined with reduced E-cadherin expression is associated with tumor progression and metastasis in pancreatic cancer
16948116 Since both S100A4 and RAGE are up-regulated in osteoarthritis cartilage, this signaling pathway could contribute to cartilage degradation in this disease.
17638890 S100A4 has a role in suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer
11786397 Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation.
12439718 association seen between S100A4 expression and aggressive breast tumor phenotype
17032501 results demonstrate frequent cytosolic overexpression of S100A2 and S100A4 in Barrett's adenocarcinoma
17219414 S100A4 protein is not expressed in benign or malignant prostatic epithelium nor in LNCaP and Du145 cells.
17328050 Overexpression of S100A4 in rheumatoid arthritis synovial tissue can influence p53 function and modulate the expression of several genes that are potentially implicated in the disease process.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.